Results 131 to 140 of about 8,948 (223)

Short- and long-term effects of early versus delayed treatment with ocrelizumab on cerebellar volume loss in patients with RMS and PPMS. [PDF]

Mult Scler
Arnold DL, Kolind S, Assemlal HE, Bar-Or A, Inglese M, Kappos L, Parmar K, Sprenger T, Traboulsee A, Vavasour IM, Wolinsky JS, Bernasconi C, Bonati U, Magon S, Tackenberg B, Gaetano L.   +15 more
europepmc   +1 more source

Elizabeth Brown

, 1945
Black-and-white photograph of contralto Elizabeth Brown, who sang with the Salt Lake Oratorio Society in ...
Seymour, Maurice
core  

Ocrelizumab Discontinuation After Recurrent Serious Infections in Clinically Stable Primary Progressive Multiple Sclerosis: A Case Report. [PDF]

Cureus
Lo T, Hassan L, Wilson S, Seri R, Hang S.   +4 more
europepmc   +1 more source

Walter Carringer [1]

, 1965
Black-and-white photograph of tenor Walter Carringer, who sang with the Salt Lake Oratorio Society in ...
Colbert Artists Management
core  

Oratorio del Crocifisso

, 2002
Analisi dell’oratorio del Crocifisso a Tolfa (Roma) Analysis of the Oratorio del Crocifisso in Tolfa ...
ZAMPA, Paola
core  

Self-Reported Temporomandibular Disorder Symptoms and Related Knowledge Among Polish Opera Singers. [PDF]

J Clin Med
Roman C, Cybulski M, Zalewska A, Czarkowska-Pączek B, Marchewka A, Rożek-Piechura K.   +5 more
europepmc   +1 more source

Late-onset severe neutropenia in patients with relapsing remitting multiple sclerosis treated with ocrelizumab: case report and literature review. [PDF]

Front Neurosci
Tauro C, Awada Z, Malhotra R, Harel A.
europepmc   +1 more source

Genome-wide study of longitudinal brain imaging measures of multiple sclerosis progression across six clinical trials. [PDF]

Sci Rep, 2023
Loomis SJ, Sadhu N, Fisher E, Gafson AR, Huang Y, Yang C, Hughes EE, Marshall E, Herman A, John S, Runz H, Jia X, Bhangale T, Bronson PG.   +13 more
europepmc   +1 more source

Pharmacodynamics and Pharmacokinetics of Ublituximab Compared with Other Anti-CD20 Monoclonal Antibodies for Multiple Sclerosis Treatment. [PDF]

Curr Neuropharmacol
Margoni M, Battistini L, Centonze D, Furlan R, Gasperini C, Filippi M.   +5 more
europepmc   +1 more source

Ocrelizumab reduces thalamic volume loss in patients with RMS and PPMS. [PDF]

Mult Scler, 2022
Arnold DL, Sprenger T, Bar-Or A, Wolinsky JS, Kappos L, Kolind S, Bonati U, Magon S, van Beek J, Koendgen H, Bortolami O, Bernasconi C, Gaetano L, Traboulsee A.   +13 more
europepmc   +1 more source